Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13800-13805

  Doores, Katie J ^a,b   Bonomelli, Camille ^c   Harvey, David J ^c   Vasiljevic, Snezana ^c   Dwek, Raymond A ^c   Burton, Dennis R ^a,b   Crispin, Max ^c   Scanlan, Christopher N ^c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

2G12; Glycosylation; gp120; HIV; Vaccine

Indexed keywords

ANTIGEN; GLYCAN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MANNOSE OLIGOSACCHARIDE; MANNOSIDASE; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; GP120 PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; MEMBRANE PROTEIN; OLIGOSACCHARIDE; POLYSACCHARIDE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; FUCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS ENVELOPE; CELL LINE; CHEMISTRY; GLYCOSYLATION; IMMUNOLOGY; KINETICS; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

ANTIGENS, VIRAL; CELL LINE; GLYCOSYLATION; GOLGI APPARATUS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; OLIGOSACCHARIDES; POLYSACCHARIDES; SIMIAN IMMUNODEFICIENCY VIRUS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 77956385205     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006498107     Document Type: Article

References (50)

1. Zhu X, Borchers C, Bienstock RJ, Tomer KB (2000) Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39:11194-11204.
2. Pantophlet R, Burton DR (2006) GP120: Target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24:739-769.
3. Wei X, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422:307-312.
4. Scanlan CN, Offer J, Zitzmann N, Dwek RA (2007) Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446:1038-1045.
5. Pancera M (2010) Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc Natl Acad Sci USA 107:1166-1171.
6. Chen L, et al. (2009) Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science 326:1123-1127.
7. Montefiori DC, Mascola JR (2009) Neutralizing antibodies against HIV-1: Can we elicit them with vaccines and how much do we need? Current Opinion in HIV and AIDS 4:347-351.
8. McMichael AJ (2006) HIV vaccines. Annu Rev Immunol 24:227-255.
9. Stamatatos L, Morris L, Burton DR, Mascola JR (2009) Neutralizing antibodies generated during natural HIV-1 infection: Good news for an HIV-1 vaccine? Nat Med 15:866-870.
10. Rerks-Ngarm S, et al.; MOPH-TAVEG Investigators (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209-2220.
11. Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631-664.
12. Varki A, et al. (2009) Essentials of Glycobiology (Cold Spring Harbor Laboratory Press, Plainview, NY), 2nd Ed.
13. Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N- acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci USA 99:13419-13424.
14. Hanisch FG, Breloy I (2009) Protein-specific glycosylation: Signal patches and cis-controlling peptidic elements. Biol Chem 390:619-626.
15. Crispin MD, et al. (2004) Monoglucosylated glycans in the secreted human complement component C3: Implications for protein biosynthesis and structure. FEBS Lett 566:270-274.
16. Iacob RE, Perdivara I, Przybylski M, Tomer KB (2008) Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans. J Am Soc Mass Spectrom 19:428-444.
17. Scanlan CN, et al. (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1→2 mannose residues on the outer face of gp120. J Virol 76:7306-7321.
18. Sanders RW, et al. (2002) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76:7293-7305.
19. Dunlop DC, et al. (2010) Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. Glycobiology 20:812-823.
20. Walker LM, et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285-289.
21. Go EP, et al. (2009) Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J Proteome Res 8:4231-4242.
22. Mizuochi T, et al. (1988) Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem J 254:599-603.
23. Crispin M, et al. (2009) A human embryonic kidney 293T cell line mutated at the Golgi α-mannosidase II locus. J Biol Chem 284:21684-21695.
24. Crispin M, et al. (2006) Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. Glycobiology 16:748-756.
25. Eggink D, et al. (2010) Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. Virology 401:236-247.
26. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21-50.
27. Scanlan CN, et al. (2007) Inhibition of mammalian glycan biosynthesis produces nonself antigens for a broadly neutralising, HIV-1 specific antibody. J Mol Biol 372:16-22.
28. Luallen RJ, et al. (2010) Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains. Glycobiology 20:280-286.
29. Geijtenbeek TB, et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
30. van Liempt E, et al. (2006) Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett 580:6123-6131.
31. Dunlop DC, et al. (2008) Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. AIDS 22:2214-2217.
32. Luallen RJ, et al. (2009) A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN. J Virol 83:4861-4870.
33. Luallen RJ, et al. (2008) An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies. J Virol 82:6447-6457.
34. Lee HK, et al. (2004) Reactivity-based one-pot synthesis of oligomannoses: Defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. Angew Chem Int Ed Engl 43:1000-1003.
35. Wang LX, Ni J, Singh S, Li H (2004) Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: Implications for HIV-1 vaccine design. Chem Biol 11:127-134.
36. Wang SK, et al. (2008) Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc Natl Acad Sci USA 105:3690-3695.
37. Krauss IJ, et al. (2007) Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody. J Am Chem Soc 129:11042-11044.
38. Dudkin VY, et al. (2004) Toward fully synthetic carbohydrate-based HIV antigen design: On the critical role of bivalency. J Am Chem Soc 126:9560-9562.
39. Balzarini J, et al. (1991) Alpha-(1-3)- and alpha-(1-6)-D-mannose- specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro. Antimicrob Agents Chemother 35:410-416.
40. Fischer PB, Karlsson GB, Butters TD, Dwek RA, Platt FM (1996) N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120. J Virol 70:7143-7152.
41. Duenas-Decamp MJ, Peters P, Burton D, Clapham PR (2008) Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop. J Virol 82:5807-5814.
42. Li Y, et al. (2008) Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. J Virol 82:638-651.
43. Wolk T, Schreiber M (2006) N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization. Med Microbiol Immunol (Berl) 195:165-172.
44. Mann AM, et al. (2009) HIV sensitivity to neutralization is determined by target and virus producer cell properties. AIDS 23:1659-1667.
45. Rusert P, et al. (2004) Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology 326:113-129.
46. Li M, et al. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79:10108-10125.
47. Aricescu AR, Lu W, Jones EY (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62:1243-1250.
48. Küster B, Wheeler SF, Hunter AP, Dwek RA, Harvey DJ (1997) Sequencing of N-linked oligosaccharides directly from protein gels: In-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal Biochem 250:82-101.
49. Harvey DJ, Royle L, Radcliffe CM, Rudd PM, Dwek RA (2008) Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem 376:44-60.
50. Harvey DJ, et al. (2009) Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics 9:3796-3801.